In theory, gene editing technology can modify many biological characteristics, including the properties of disease vectors. However, the use of gene editing to enhance the transmission ability of disease vectors is a highly controversial issue both ethically and scientifically. 1. **Technical feasibility**: Gene editing technologies such as CRISPR-Cas9 can precisely modify the genome of an organism. Scientists have used it in the laboratory to change the genes of mosquitoes to inhibit the transmission of diseases such as malaria and dengue fever. However, this is mainly to reduce disease transmission, not enhance it. 2. **Ethical issues**: Deliberately enhancing the transmission ability of disease vectors raises serious ethical issues. Such behavior violates the Biosafety Protocol and multiple international conventions because it may have unpredictable and potential harm to human health and ecosystems. 3. **Actual risks**: The introduction of gene-edited organisms into ecosystems may have far-reaching effects on the natural world. Enhancing the ability of disease vectors may lead to uncontrollable disease outbreaks and pose a serious threat to public health. 4. **The position of the scientific community**: At present, the scientific community and the laws and regulations of most countries strongly oppose the use of gene editing for destructive purposes. The research and application of gene editing usually need to follow strict ethical and regulatory guidelines. In summary, although gene editing technology has great potential, its application must be strictly evaluated and regulated to ensure that it is used to benefit humans and the environment rather than cause harm.